Selina J Chavda

Genomic Profiling of Smoldering Multiple Myeloma Identifies Patients at a High Risk of Disease Progression

Mark Bustoros, Romanos Sklavenitis‐Pistofidis, Jihye Park et al. · Journal of Clinical Oncology · 2020 · 182 citations · Full text

Medicine, Molecular Genetics, Oncology +12

Personalised progression prediction in patients with monoclonal gammopathy of undetermined significance or smouldering multiple myeloma (PANGEA): a retrospective, multicohort study

Annie Cowan, Federico Ferrari, Samuel S. Freeman et al. · The Lancet Haematology · 2023 · 80 citations · Full text

Medicine, Hematology, Oncology +17

Clinical outcomes and risk factors for severe COVID‐19 in patients with haematological disorders receiving chemo‐ or immunotherapy

Thomas A. Fox, Ethan Troy‐Barnes, Amy A. Kirkwood et al. · British Journal of Haematology · 2020 · 76 citations · Full text

Medicine, Clinical Sciences, Hematology +13

Marrow-Infiltrating Regulatory T Cells Correlate with the Presence of Dysfunctional CD4+PD-1+ Cells and Inferior Survival in Patients with Newly Diagnosed Multiple Myeloma

Nouf M. Al‐Rasheed, Lydia Lee, Ehsan Ghorani et al. · Clinical Cancer Research · 2020 · 71 citations · Full text

Life Sciences, Hematology, Immunology +17

Genetic subtypes of smoldering multiple myeloma are associated with distinct pathogenic phenotypes and clinical outcomes

Mark Bustoros, Shankara Anand, Romanos Sklavenitis‐Pistofidis et al. · Nature Communications · 2022 · 33 citations · Full text

Medicine, Genetics, Oncology +17